Lene Terslev1,2, Cecilie Heegaard Brahe3, Mikkel Østergaard3,4, Viktoria Fana3, Mads Ammitzbøll-Danielsen3, Torsten Møller3, Simon Krabbe3, Merete Lund Hetland3,4, Uffe Møller Døhn3. 1. Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Glostrup, Copenhagen, Denmark. lene.terslev.01@regionh.dk. 2. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. lene.terslev.01@regionh.dk. 3. Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Glostrup, Copenhagen, Denmark. 4. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Abstract
BACKGROUND: Subclinical synovitis by ultrasound is a frequent finding in rheumatoid arthritis (RA) patients in remission and has been shown to be related to erosive progression, risk of flare and unsuccessful drug tapering, but it has not been investigated how a DAS28 T2T-steered strategy in routine care affects the presence of subclinical synovitis in RA patients in remission. The aim of the current study was to investigate the presence of ultrasound-detected subclinical inflammation in RA patients in long-term remission receiving either biological or conventional disease-modifying anti-rheumatic drugs (bDMARD/csDMARD) and, finally, to investigate the presence of ultrasound remission using different ultrasound remission criteria. METHODS: Eighty-seven RA patients (42 patients receiving bDMARD and 45 csDMARD) received DAS28-CRP-steered treatment in routine care and had achieved DAS28-CRP-remission for > 1 year without radiographic progression. Twenty-four joints were scored 0-3 by ultrasound (elbows, wrists, knees, ankles, metacarpophalangeal and metatarsophalangeal joints 2-5) for grey-scale synovial hypertrophy (GS) and colour Doppler activity (CD) using the OMERACT scoring system. Ultrasound remission was defined as strict (GS score = 0 and CD score = 0), semi-strict (GS score < 1 and Doppler score = 0) and Doppler remission (Doppler score = 0). RESULTS: No differences between treatment groups were found for GS sum score and Doppler sum score (median (range) 6 (0-19) and 0 (0-12), respectively). A Doppler score > 0 in at least 1 joint was seen in 44%, a GS score > 1 in at least 1 joint in 93% and a GS score > 2 in at least 1 joint in 54% of patients. Strict ultrasound remission was only observed in bDMARD patients (7%; p = 0.01). Thirty-seven per cent were in semi-strict ultrasound remission and 56% in Doppler remission (no significant difference between groups) with similar results across the subgroups of patients who also fulfilled the ACR-EULAR Boolean-, CDAI- and SDAI-remission criteria. CONCLUSIONS: Ultrasound frequently detected subclinical synovitis in RA patients in longstanding DAS28-remission obtained through a DAS28-CRP-steered strategy. This was independent of treatment and applied ultrasound remission criteria. Strict ultrasound remission was rare.
BACKGROUND: Subclinical synovitis by ultrasound is a frequent finding in rheumatoid arthritis (RA) patients in remission and has been shown to be related to erosive progression, risk of flare and unsuccessful drug tapering, but it has not been investigated how a DAS28 T2T-steered strategy in routine care affects the presence of subclinical synovitis in RApatients in remission. The aim of the current study was to investigate the presence of ultrasound-detected subclinical inflammation in RApatients in long-term remission receiving either biological or conventional disease-modifying anti-rheumatic drugs (bDMARD/csDMARD) and, finally, to investigate the presence of ultrasound remission using different ultrasound remission criteria. METHODS: Eighty-seven RApatients (42 patients receiving bDMARD and 45 csDMARD) received DAS28-CRP-steered treatment in routine care and had achieved DAS28-CRP-remission for > 1 year without radiographic progression. Twenty-four joints were scored 0-3 by ultrasound (elbows, wrists, knees, ankles, metacarpophalangeal and metatarsophalangeal joints 2-5) for grey-scale synovial hypertrophy (GS) and colour Doppler activity (CD) using the OMERACT scoring system. Ultrasound remission was defined as strict (GS score = 0 and CD score = 0), semi-strict (GS score < 1 and Doppler score = 0) and Doppler remission (Doppler score = 0). RESULTS: No differences between treatment groups were found for GS sum score and Doppler sum score (median (range) 6 (0-19) and 0 (0-12), respectively). A Doppler score > 0 in at least 1 joint was seen in 44%, a GS score > 1 in at least 1 joint in 93% and a GS score > 2 in at least 1 joint in 54% of patients. Strict ultrasound remission was only observed in bDMARDpatients (7%; p = 0.01). Thirty-seven per cent were in semi-strict ultrasound remission and 56% in Doppler remission (no significant difference between groups) with similar results across the subgroups of patients who also fulfilled the ACR-EULAR Boolean-, CDAI- and SDAI-remission criteria. CONCLUSIONS: Ultrasound frequently detected subclinical synovitis in RApatients in longstanding DAS28-remission obtained through a DAS28-CRP-steered strategy. This was independent of treatment and applied ultrasound remission criteria. Strict ultrasound remission was rare.
Authors: Garifallia Sakellariou; Carlo Alberto Scirè; Suzanne M M Verstappen; Carlomaurizio Montecucco; Roberto Caporali Journal: Ann Rheum Dis Date: 2012-10-11 Impact factor: 19.103
Authors: James Dale; Anne Stirling; Ruiqi Zhang; David Purves; Jonathan Foley; Martin Sambrook; Philip G Conaghan; Désirée van der Heijde; Alex McConnachie; Iain B McInnes; Duncan Porter Journal: Ann Rheum Dis Date: 2016-03-29 Impact factor: 19.103
Authors: Ingrid Möller; Iustina Janta; Marina Backhaus; Sarah Ohrndorf; David A Bong; Carlo Martinoli; Emilio Filippucci; Luca Maria Sconfienza; Lene Terslev; Nemanja Damjanov; Hilde Berner Hammer; Iwona Sudol-Szopinska; Walter Grassi; Peter Balint; George A W Bruyn; Maria Antonietta D'Agostino; Diana Hollander; Heidi J Siddle; Gabriela Supp; Wolfgang A Schmidt; Annamaria Iagnocco; Juhani Koski; David Kane; Daniela Fodor; Alessandra Bruns; Peter Mandl; Gurjit S Kaeley; Mihaela Micu; Carmen Ho; Violeta Vlad; Mario Chávez-López; Georgios Filippou; Carmen Elena Cerón; Rodina Nestorova; Maritza Quintero; Richard Wakefield; Loreto Carmona; Esperanza Naredo Journal: Ann Rheum Dis Date: 2017-08-16 Impact factor: 19.103
Authors: Espen A Haavardsholm; Anna-Birgitte Aga; Inge Christoffer Olsen; Siri Lillegraven; Hilde B Hammer; Till Uhlig; Hallvard Fremstad; Tor Magne Madland; Åse Stavland Lexberg; Hilde Haukeland; Erik Rødevand; Christian Høili; Hilde Stray; Anne Noraas; Inger Johanne Widding Hansen; Gunnstein Bakland; Lena Bugge Nordberg; Désirée van der Heijde; Tore K Kvien Journal: BMJ Date: 2016-08-16
Authors: Diana Vossen; Johannes Knitza; Philipp Klemm; Isabell Haase; Johanna Mucke; Anna Kernder; Marco Meyer; Arnd Kleyer; Philipp Sewerin; Gerlinde Bendzuck; Sabine Eis; Martin Krusche; Harriet Morf Journal: Z Rheumatol Date: 2021-08-27 Impact factor: 1.530